Crocs vs NIKE
CROX and NKE side by side, both in rubber and miscellaneous plastics products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CROX and NKE compare
NIKE is the larger company, worth 7.9 times as much as Crocs ($57.4B against $7.2B).
On earnings, Crocs is cheaper: it trades at 11.2× trailing earnings, against 18.6× for NIKE.
Crocs grew revenue faster over the last twelve months (0.70% versus −1.2% for NIKE).
Crocs keeps more of each dollar of sales as profit, with a net margin of 16.2% compared with 6.7% at NIKE.
NIKE pays a dividend yielding 4.2%; Crocs does not pay one.
NIKE scores higher on the StockData Score (16 against 14 for Crocs), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CROX | NKE |
|---|---|---|
| Size and price | ||
| Market cap | $7.2B | $57.4B |
| Share price | $150.52 | $38.67 |
| Change, 1 year | 77.7% | −40.8% |
| Change, 5 years | −16.5% | −78.2% |
| Beta (5Y) | 1.29 | 1.02 |
| Employees | 8,010 | 73K |
| StockData Score | ||
| Total score | 14 | 16 (better) |
| Valuation score | 4 (better) | 3 |
| Growth score | 2 | 2 |
| Performance score | 4 (better) | 3 |
| Health score | 4 | 4 |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | 11.2× (better) | 18.6× |
| P/S | 1.8× | 1.3× (better) |
| P/B | 5.4× | 3.8× (better) |
| EV/EBITDA | 8.3× (better) | 12.6× |
| P/FCF | 9.6× (better) | 27.3× |
| FCF yield | 10.4% (better) | 3.7% |
| Fair value | $205.39 | $47.64 |
| Margin of safety | 26.7% (better) | 18.8% |
| Growth | ||
| Revenue growth (TTM) | 0.70% (better) | −1.2% |
| Revenue growth, 5Y average | 23.9% (better) | 0.82% |
| Net income growth (TTM) | 264% (better) | 6.8% |
| EPS growth (TTM) | 337% (better) | 6.7% |
| EPS growth, 5Y average | – | −10.0% |
| Profitability | ||
| Gross margin | 59.4% (better) | 43.1% |
| Operating margin | 22.6% | – |
| Net margin | 16.2% (better) | 6.7% |
| FCF margin | 18.4% (better) | 4.6% |
| Return on equity | 49.1% (better) | 21.6% |
| Return on invested capital | 29.0% | – |
| Financial health | ||
| Debt / equity | 0.96 | 0.52 (better) |
| Net debt / EBITDA | 1.12 | 0.21 (better) |
| Interest coverage | 11.5× | – |
| Current ratio | 1.44 | 2.07 (better) |
| Altman Z-score | 4.56 (better) | 3.13 |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 4.2% |
| Payout ratio | – | 78.4% |
| Years of dividend growth | – | 17 |
| Dividend growth, 5Y average | – | 8.8% |
| Buyback yield | 9.5% (better) | 0.03% |
| Shareholder yield | 9.5% (better) | 4.3% |
| Ownership | ||
| Held by institutions | 101% | 65.0% |
| Held by insiders | 5.0% | 15.7% |
| Insider net buying, 12 months | −$9.4M | $1.5M (better) |
| Superinvestors holding | 5 (better) | 3 |
| Short interest, % of float | 10.9% | 7.9% |
Go deeper
- CROX stock overview
- CROX income statement
- CROX valuation and score
- NKE stock overview
- NKE income statement
- NKE valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.